Evidence map›Paper›PMID 35800184›Full record

SynthesisWorld journal of gastroenterology2022

Endoscopic ultrasound-guided injectable therapy for pancreatic cancer: A systematic review.

Jyotroop Kaur, Veeravich Jaruvongvanich, Vinay Chandrasekhara

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in World journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Current status of endoscopic ultrasound-guided antitumor treatment for pancreatic cancer.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jyotroop KaurDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, United States.
Veeravich JaruvongvanichDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, United States.
Vinay ChandrasekharaDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, United States. chandrasekhara.vinay@mayo.edu.
Mayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven the low survival rate in pancreatic cancer, new therapeutic techniques have been explored, especially for unresectable or borderline resectable disease. Endoscopic ultrasound (EUS) provides real-time imaging and minimally invasive access for local and targeted injection of anti-tumor agents directly into the pancreatic tumor. Limited studies have been reported using this technique for the treatment of pancreatic ductal adenocarcinoma (PDAC).

aimTo evaluate the progress made with EUS-guided injectable therapies in the treatment of PDAC.

methodsAll original articles published in English until July 15, 2021, were retrieved

resultsA total of thirteen articles (503 patients) were found eligible for inclusion. The EUS-injectable therapies used were heterogeneous among the studies consisting of immunotherapy (

conclusionEUS-guided injectable therapies, including immunotherapy, chemotherapy, and viral or other biological therapies have shown minimal adverse events and potential efficacy in the treatment of PDAC. Comparative studies, including controlled trials, are required to confirm these results in order to offer novel EUS-based treatment options for patients with PDAC.

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsAdenocarcinomaEndoscopic Ultrasound-Guided Fine Needle AspirationHumansProspective StudiesChemotherapyEndoscopic ultrasound-guided fine-needle injectionImmunotherapyLocal injectable therapyOncolytic viral therapyPancreatic ductal adenocarcinoma

Identifiers

PMID35800184
PMCPMC9185216
OpenAlexW4283367319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.